Financial Express runs a commentary on the Indian Initiative for Open Source Drug Discovery for neglected diseases.
If you thought the adoption of open source was restricted to only software—web servers, code development, and operating systems— then think again. The open source wave could soon power drug discovery initiatives in the country. A decentralised, web-based initiative is emerging that would enable scientists from laboratories, universities, institutes, and drug Companies to work together in discovering new drugs for diseases like tuberculosis (TB), malaria, various types of cancer, AIDS, Chikungunya, Kala-azar, dengue fever, etc. Not only would drugs be made available to the public at affordable prices, there are monetary gains for the participating researchers in the form of awards and prizes.
Open source drug discovery would have independent biologists freely sharing their work through the internet.